Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy.
Association of early versus delayed normalisation of left ventricular ejection fraction with mortality in ischemic cardiomyopathy.
复制标题
缺血性心肌病患者左室射血分数早期和延迟恢复正常与死亡率的关系。
DOI:
10.1136/openhrt-2020-001528
复制
发表时间:
2021-03
期刊:
影响因子:
2.7
通讯作者:
Adamo L
中科院分区:
文献类型:
--
作者:
Schiffer WB;Perry A;Deych E;Brown DL;Adamo L
In patients with non-ischaemic cardiomyopathy and reduced left ventricular ejection fraction (LVEF), normalisation of LVEF is associated with improved outcomes. However, data on patients with ischaemic cardiomyopathy and recovered LVEF are lacking. The goal of this study was to assess the prognostic significance of normalisation of the LVEF in patients with ischaemic cardiomyopathy. We performed a non-prespecified post hoc analysis of the Surgical Treatment for Ischaemic Heart Failure (STICH) trial to determine the association between normalisation of LVEF (>50%) and mortality during follow-up. Of the 1212 patients with LVEF <35% enroled in the STICH trial, 932 underwent assessment of LVEF at 4 months and/or 2 years after enrolment. Among them, 18 patients experienced normalisation in LVEF at 4-month follow-up and 35 patients experienced recovery in LVEF at 2 years. Recovery of LVEF at 4 months and recovery of LVEF at 2 years were not correlated. Recovery of LVEF at 4 months was not associated with reduced all-cause mortality in unadjusted analysis (log-rank test p=0.54) or in Cox proportional hazards analysis (HR: 0.93; 95% CI: 0.48 to 1.80; p=0.82). Ejection fraction recovery at 2 years was associated with a reduction in all-cause mortality, both in unadjusted analysis (log-rank test p=0.004) and in the Cox proportional hazard model (HR: 0.41; 95% CI: 0.21 to 0.80; p=0.009). In patients with ischaemic cardiomyopathy, delayed normalisation of LVEF is associated with reduced mortality, whereas early recovery of LVEF is not. Further studies are needed to confirm these findings.
登录
查看更多内容
影响因子:
7.5
作者:
Klem, Igor;Shah, Dipan J.;Kim, Raymond J.
通讯作者:
Kim, Raymond J.
影响因子:
18.2
作者:
Lupon, Josep;Diez-Lopez, Carles;Bayes-Genis, Antoni
通讯作者:
Bayes-Genis, Antoni
DOI:
10.1056/nejmoa1602001
发表时间:
2016-04-21
期刊:
The New England journal of medicine
影响因子:
--
作者:
Velazquez EJ;Lee KL;Jones RH;Al-Khalidi HR;Hill JA;Panza JA;Michler RE;Bonow RO;Doenst T;Petrie MC;Oh JK;She L;Moore VL;Desvigne-Nickens P;Sopko G;Rouleau JL;STICHES Investigators
通讯作者:
STICHES Investigators
DOI:
10.1056/nejmoa1100356
发表时间:
2011-04-28
期刊:
The New England journal of medicine
影响因子:
--
作者:
Velazquez EJ;Lee KL;Deja MA;Jain A;Sopko G;Marchenko A;Ali IS;Pohost G;Gradinac S;Abraham WT;Yii M;Prabhakaran D;Szwed H;Ferrazzi P;Petrie MC;O'Connor CM;Panchavinnin P;She L;Bonow RO;Rankin GR;Jones RH;Rouleau JL;STICH Investigators
通讯作者:
STICH Investigators
影响因子:
8.1
作者:
Monge Garcia, Manuel Ignacio;Jian, Zhongping;Pinsky, Michael R.
通讯作者:
Pinsky, Michael R.